The objective of this study was to evaluate the effects of trazodone as part of premedication in routine surgical procedures. A prospective, randomized, double-blinded clinical study was conducted on 16 adult female dogs undergoing elective ovariectomy. Behavioral responses were assessed after oral administration of trazodone (5 mg/kg) in eight dogs and compared with a control group (n = 8). Sedation levels at the time of induction and the required dose of propofol were recorded. Additionally, intraoperative fentanyl IV boluses (2.5 µg/kg) administered in response to surgical pain, along with heart rate (HR) and non-invasive arterial pressure (NIAP), were compared between groups. Dogs receiving trazodone exhibited significantly lower stress scores on the Clinic Dog Stress Scale (CDSS) and fewer episodes of vomiting after premedication, and they required lower doses of both propofol and intraoperative analgesia. These findings suggest that oral trazodone administration two hours before hospital arrival may help reduce preoperative stress in dogs undergoing elective ovariectomy. However, further studies with larger sample sizes are needed to confirm these results and fully evaluate the role of trazodone in preoperative protocols.
Preoperative anxiety may compromise perioperative welfare and anesthetic management in dogs. This randomized, blind clinical study evaluated the effects of oral tasipimidine on anxiety-related behaviors, handling quality, cardiovascular variables, anesthetic requirements and recovery in dogs undergoing elective ovariectomy. Thirty ASA I dogs were randomly allocated into three groups (n = 10). Treatment groups received tasipimidine (30 µg/kg PO) 45 min before admission, followed by morphine (0.3 mg/kg IM) combined with dexmedetomidine at either 2.5 µg/kg (GTa) or 5 µg/kg IM (GTb). Control dogs (GC) received an oral placebo followed by dexmedetomidine (5 µg/kg IM) and morphine (0.3 mg/kg IM). Anxiety was assessed using the Clinic Dog Stress Scale (CDSS), Visual Analog Scale (VAS), and Reactivity Evaluation Form (REF). Handling quality was assessed using a Numerical Rating Scale (NRS), and recovery quality using the Simple Descriptive Scale (SDS). Tasipimidine significantly reduced anxiety-related behaviors compared with controls, with lower CDSS (5 [0–10] vs. 13 [3–19]), VAS (4 [2–7] vs. 6.5 [2–9]), and REF scores (1 [1–3] vs. 2 [1–4]) (p < 0.05). Handling quality improved significantly in treated dogs with lower NRS (1 [1–2] vs. 2 [1–4]; p = 0.003). Preoperative heart rate was lower in tasipimidine-treated dogs (85 ± 19 bpm) than in controls (127 ± 23 bpm; p < 0.001). Recovery agitation requiring dexmedetomidine rescue sedation occurred in 30% of treated dogs versus 60% of controls. Propofol and fentanyl requirements did not differ significantly among groups (p > 0.05). Tasipimidine improved anxiety-related behavioral scores and handling quality in dogs; however, its cardiovascular effects and perioperative role warrant further investigation.